The Harvard Drug Group recalls Gabapentin Tablets, USP 600 mg, packaged in Cartons of 100 tablets (10 tablets per blister pack x 10), Rx Only, Distrib…
- Recall date
- April 24, 2023
- Source
- U.S. Food & Drug Administration (FDA) — enforcement report
- Recall number
- D-0570-2023
- FDA classification
- Class III
- Brand / firm
- The Harvard Drug Group
- Sold / distributed
- USA Nationwide
Why it was recalled
Product mixup: one foreign tablet found in product.
Class III means the product violates regulations but is not likely to cause harm.
What was recalled
Gabapentin Tablets, USP 600 mg, packaged in Cartons of 100 tablets (10 tablets per blister pack x 10), Rx Only, Distributed by: Aurobindo Pharma USA, Inc. East Windsor, NJ 08520 Distributed by: Major Pharmaceuticals 17177 N Laurel Park Dr., Suite 233 Livonia, MI 48152 USA, NDC 0904-6823-61
Get recall alerts
Free email alert whenever The Harvard Drug Group has a new recall — straight from official government data. Unsubscribe anytime.
More recalls from: The Harvard Drug Group